Redefining the value in partnerships ahead of DCAT Week

As the industry emerges from a prolonged funding slowdown, the roundtable highlights cautious optimism. Rather than a broad-based recovery, participants describe a selective, research-driven uptick focused on clinic-ready assets and higher-complexity modalities. Discussions have shifted from speculative experimentation to practical considerations, including manufacturability, timeline efficiency and the ability to scale reliably. This suggests growth that is deliberate, technology selective and weighted toward assets with clearer commercial pathways.

LATEST VIDEO

Latest news

16th June 2026

Neuland to open $20m dedicated Process Development facility with integrated kilo labs in Hyderabad

16th June 2026

Mabion reactivates MabionCD20 through rare disease collaboration with Oddifact

15th June 2026

VIVEbiotech adds newest in vivo lentiviral vector-based therapeutic programs

15th June 2026

Lonza Grants Exclusive, Target-Specific License to Antharis Therapeutics to Advance Next-Generation Dual Payload ADCs for Gastrointestinal Cancers

15th June 2026

ZoBio launches comprehensive DEL hit discovery service for challenging targets

15th June 2026

CPHI launches new Sustainability Summit as pharma faces growing pressure to deliver sustainability goals

12th June 2026

GELITA Unveils Next-Generation Excipient Innovations at BIO International 2026 in San Diego

11th June 2026

Johnson & Johnson Expands Oncology Pipeline with $1 Billion Firefly Bio Acquisition

10th June 2026

Axplora consolidates UDCA manufacturing at Vizag site to strengthen integrated global supply and support future growth

10th June 2026

Symeres expands spray drying capabilities to accelerate complex small molecule development

9th June 2026

AmMax Bio Licenses Antibody-Drug Conjugate Technology for Hematological Cancers from Lonza

This week’s featured articles

A woman’s view from the HAS Group

Breaking Barriers: Women Scientists Rising to Leadership in Pharma

Strategic Growth in Biologics Manufacturing: Insights from Lonza's Acquisition of the Vacaville Site

Grifols’ supply chain strategy offers lessons beyond saline

Axplora: Mastering complexity

Partnered with top industry events and organisations